[Elsevier] Abemaciclib plus a nonsteroidal aromatase inhibitor as initial therapy for HR+, HER2- advanced breast cancer: Final overall survival results of MONARCH 3

 Close Closed
RaiFazal Post time 2024-5-9 19:24:46 | Show all posts |Read mode
Reward10points

journal£ºAnnals of Oncology

Authors£ºM.P. Goetz; M. Toi; J. Huober; J. Sohn; O. Tr¨¦dan; I.H. Park; M. Campone; S.-C. Chen; L.M. Manso; S. Paluch-Shimon; O.C. Freedman; J. O'Shaughnessy; X. Pivot; S.M. Tolaney; S. Hurvitz; A. Llombart-Cussac; V. Andr¨¦; A. Saha; G. van Hal; A. Shahir; H. Iwata; S.R.D. Johnston

Published date£º2024-5-

DOI£º10.1016/j.annonc.2024.04.013

PDF link£ºhttps://www.sciencedirect.com/sc ... 92375342400139X/pdf

Article link£ºhttp://dx.doi.org/10.1016/j.annonc.2024.04.013

Article Source£ºElsevier BV¡£


Remark£º
Reply

Use magic Donate Report

All Reply0 Show all posts

Reply

You have to log in before you can reply Login | Register

Points Rules

Senior Member
  • post

  • reply

  • points

    740

Latest Reply

Return to the list